Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : PSFT - Fiscal 1998 - Discussion for the next year -- Ignore unavailable to you. Want to Upgrade?

To: Marq Spencer who wrote (3566)	11/17/1998 11:19:00 AM
From: melinda abplanalp	Read Replies (1) \| Respond to of 4509

Can you BUY stock in the NEW company? Melinda

To: Marq Spencer who wrote (3566)	11/17/1998 1:05:00 PM
From: Chuzzlewit	Read Replies (1) \| Respond to of 4509

Brian, the $300 MM isn't an expense item, it's equity. I'm certain that the rights referred to would not extend to R&D done of behalf of PSFT competitors. I really don't know what to make of this deal. TTFN, CTC

To: Marq Spencer who wrote (3566)	11/17/1998 1:27:00 PM
From: Lizzie Tudor	Read Replies (1) \| Respond to of 4509

I'm kind of disgusted because what PSFT is implying is that R&D is not really part of their business, and therefore, expense. That is absurd for a hi-tech company and quite the opposite of the way a small, nimble company represents itself. Hmmm... I disagree a little. Psft acquires their technology generally , we all know that, and its a strength. Csco and psft mgmt know that large companies are not condusive to retaining top technical talent or new ideas etc. The acquisition strategy is the right one, vs Oracles NIH strategy which does not work for this type of technology in this decade. Ill bet psft looked at acquiring a company and couldnt find one. They now are trying to apply their model of using small companies to generate innovation by spinning off this entity or whatever it is. I dont know much about the financial issues here (or any financial issues for that matter) but just speaking from an R&D managers perspective it looks like this is just another slant on the way they typically operate with new technological spaces. BTW this also implies that they wont buy Ariba - good. Michelle